Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-09

Clinical Trial Update: Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis C [Phase 2]

View source ↗

Summary

The update covers the completion of a Phase 2 trial evaluating Silybum Marianum (milk thistle) for chronic hepatitis C. Sponsor: Isfahan University of Medical S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silybum Marianum (Silybum marianum)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED